期刊文献+

强直性脊柱炎活动期VEGF和TNF-α在棘间韧带组织中mRNA表达水平的检测 被引量:9

Expressions of VEGF and TNF-α in interspinous ligament of patients with ankylosing spondylitis in active stage
下载PDF
导出
摘要 目的探讨血管内皮生长因子(vascular endothelial growth factor,VEGF)和肿瘤坏死因子(tumor nerosis factor,TNF-α)在强直性脊柱炎(ankylosing spondylitis,AS)活动期患者棘间韧带的病理性表达水平。方法通过原位杂交技术检测活动期AS患者与对照组棘间韧带组织中TNF-αmRNA、VEGF mRNA的表达,用图像分析系统比较它们的表达差异,并与疾病的活动指数、CRP进行相关性分析。结果在活动期AS患者棘间韧带组织中TNF-α mRNA、VEGF mRNA呈阳性表达,而对照组棘间韧带组织中TNF-α mRNA、VEGF mRNA呈阴性表达,阳性细胞计数和图像灰度值比较有统计学差异(P<0.01)。VEGF mRNA、TNF-α mRNA的表达与AS疾病活动指数(BASDAI)和CRP显著相关(r=0.53,r=0.42,P<0.05)。结论VEGF可能是强直性脊柱炎发病过程中的重要因子之一,TNF-α作为1个核心的调控因子,在强直性脊柱炎发病机制中也起着重要作用。 Objective To detect the pathological expressions of TNF-α and VEGF in interspinous ligament of patients with ankylosing spondylitis(AS) in active stage. Methods The expressions of TNF-α mRNA and VEGF mRNA in the interspinous ligament of patient with AS group and control group were detected by hybridization in situ. Their different results were compared by image analysis system and the correlation between TNF-α mRNA, VEGF mRNA and both AS disease active index (DAI) and C reactive protein (CRP) was analysed respectively. Results The expressions of TNF-α mRNA and VEGF mRNA in the interspinous ligament of patients with active AS were positive, but those of the control group were negtive. Statistical differences existed in the positive cell numbers and in image gray scale value of AS group (P 〈0. 01 ). Significant correlation was observed between the expression of VEGF, TNF-α and CRP, BASDAI (P 〈0. 05). Conclusion VEGF are the important factors in the pathological process in patients with active AS. TNF-α, a core reguahing factor, also plays an significant role in the pathogenesis of AS.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第15期1459-1461,共3页 Journal of Third Military Medical University
关键词 强直性脊柱炎 TNF-Α VEGF 原位杂交技术 ankylosing spondylitis TNF-α VEGF hybridization in situ
  • 相关文献

参考文献13

  • 1Drouart M, Saas P, Billot M, et al. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies [ J]. Clin Exp Immunol, 2003, 132( 1 ) : 158 - 162.
  • 2初同伟,王正国,朱佩芳,焦文仓,温建良,龚水根.血管内皮生长因子在骨折愈合中的作用[J].中国修复重建外科杂志,2002,16(2):75-78. 被引量:41
  • 3王哲,王全平,张俊华,李靖,吕荣.骨形成蛋白在黄韧带骨化中的表达定位[J].第四军医大学学报,2002,23(4):341-343. 被引量:22
  • 4Seo J S, Lee S S, Kim S I, et al. Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis [ J ]. Rheumatology (Oxford), 2005, 44(10) : 1299 - 1302.
  • 5Bouletreau P J, Warren S M, Spector J A, et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing [ J ]. Plast Reconstr Surg, 2002, 109(7): 2384-2397.
  • 6Duyndam M C , Hilhorst M C , Schluper H M, et al. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts[J]. Am J Pathol, 2002, 160(2) : 537 -548.
  • 7张海俊,张思争,林星,等.类风湿关节炎的治疗[M]//蒋明,DAVID YU,林孝义,等.中华风湿病学.北京:华夏出版社,2004:771-824.
  • 8Maksymowych W P, Jhangri G S, Lambert R G, et al. Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety[J]. J Rheumatol, 2002, 29(5) : 959 -965.
  • 9Yang C, Gu J, Rihl M, et al. Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis[ J]. Arthritis Rheum, 2004, 51 (5): 691 - 699.
  • 10Cha H S, Bae E K, Koh J H, et al. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes[ J]. J Rheumatol, 2007, 34( 1 ) : 16 - 19.

二级参考文献22

  • 1林剑浩,吕厚山,陈占昆,蒋东芳,王申五,冯传汉.中国人群HLA-B_(27)等位基因亚型与强直性脊柱炎的相关性研究[J].北京医科大学学报,1994,26(5):323-326. 被引量:19
  • 2Siwik DA, Chang DL, Colucci WS. Interliukin-1βand tumor necrosis factor-α decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro [J]. Circ Res, 2000; 86(12):1259-1265.
  • 3Kubota A, Hasegawa K, Suguro T, et al. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts [J]. J Rheumatol, 2004; 31(3):426-435.
  • 4Blair HC, Athanasou NA. Recent advances in osteoclast biology and pathological bone resorption[J]. Histol Histopathol, 2004;19(1):189-199.
  • 5Hofbauer LC, Hicok KC, Chen D, et al. Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells [J]. Eur J Endocrinol, 2002;147(2): 269-273.
  • 6Kodo O, Sabokbar A, Itonaga I, et al. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism [J]. Bone, 2003; 32(1):1-7.
  • 7Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factors alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction[J]. J Exp Med, 2000;191(2):275-286.
  • 8Kudo O, Fujikawa Y, Itonaga I, et al. Proinflammatory cytokine (TNFα/IL-1α) induction of human osteoclast formation [J]. J Pathol, 2002; 198(2):220-227.
  • 9Lam J, Takeshita S, Barker JE, et al. TNFα induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand[J]. J Clin Inves, 2000; 106(12):1481-1488.
  • 10Witten PE, Hansen A, Hall BK. Features of mono- and multinucleated bone resorbing cells of the Zebrafish Danio rerio and their contribution to skeletal development, remodeling, and growth [J]. J Morphol, 2001; 250(3): 197-207.

共引文献101

同被引文献71

  • 1Vanden LS,Valkenburg HA,Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria.Arthritis Rheum,1984,27:361-368.
  • 2Park MC,Lee SW,Choi ST,et al.Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.Seand J Rheumatol,2007,36:101-106.
  • 3Yoon YS,Johnson IA,Park JS,et al.Therapeutic myocardial angiogenesis with vascular endothelial growth factor.Mol Cell Biochem,2004,264:63-74.
  • 4Lee S,Joo YS,Kim WU,et al.Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis.Clin Exp Rheumatol,2001,19:321-314.
  • 5Pinheiro GR,Andrade CA,Gayer CR,et al.Serum vascular endothelial growth factor in late rheumatoid arthritis.Clin Exp Rheumatol,2001,19:721-723.
  • 6Maksymowych WP,Jhangri GS,Lambert RG,et al.Infliximab in ankylosing spondylitis:a prospective observational inception cohort analysis of efficacy and safety.J Rheumatol,2002,29:959-965.
  • 7Yang C,Gu J,Rihl M,et al.Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis.Arthritis Rheum,2004,51:691-699.
  • 8Drouart M,Saas P,Billot M,et al.High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies.Clin Exp Immunol,2003,132:158-162.
  • 9Goldberger C,Dulak J,Duftner C,et al.Vascular endothelial growth factor(VEGF) in ankylosing spondylitis-a pilot study.Wien Med Wochenschr,2002,152:223-225.
  • 10Visvanathan S,Wagner C,Marini JC,et al.Inflammatory biomarkers,disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.Ann Rheum Dis,2008,67:511-517.

引证文献9

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部